T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$2.03B |
| 2 |
Rockwell Automation
ROK
|
+$1.44B |
| 3 |
Autodesk
ADSK
|
+$1.15B |
| 4 |
Citigroup
C
|
+$975M |
| 5 |
ConocoPhillips
COP
|
+$967M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.59B |
| 2 |
GE Aerospace
GE
|
+$1.78B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.21% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Communication Services | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Inovio Pharmaceuticals
INO
$93M
| $174K | ﹤0.01% |
12,499
-1
| -0% | -$9 |
|
2652
Perella Weinberg Partners
PWP
$1.32B
| $174K | ﹤0.01% |
12,306
+1,753
| +17% | +$22K |
|
2653
Shattuck Labs
STTK
$729M
| $173K | ﹤0.01% |
19,300
| – | – |
|
2654
nLIGHT
LASR
$2.9B
| $172K | ﹤0.01% |
13,154
+1,886
| +17% | +$24.7K |
|
2655
ClearPoint Neuro
CLPT
$471M
| $170K | ﹤0.01% |
24,867
+1,813
| +8% | +$12.7K |
|
|
KREF
2656
KKR Real Estate Finance Trust
KREF
$500M
| $170K | ﹤0.01% |
16,846
+2,481
| +17% | +$27.2K |
|
2657
Treace Medical Concepts
TMCI
$305M
| $170K | ﹤0.01% |
12,972
+1,385
| +12% | +$18.5K |
|
2658
Ribbon Communications
RBBN
$377M
| $169K | ﹤0.01% |
52,535
-24,566
| -32% | -$74.7K |
|
|
PKST
2659
DELISTED
Peakstone Realty Trust
PKST
| $168K | ﹤0.01% |
+10,377
| New | +$159K |
|
2660
Rigel Pharmaceuticals
RIGL
$763M
| $168K | ﹤0.01% |
11,305
+912
| +9% | +$12.3K |
|
2661
Savara
SVRA
$1.09B
| $168K | ﹤0.01% |
33,692
+4,625
| +16% | +$22.3K |
|
|
LGF.A
2662
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $167K | ﹤0.01% |
16,688
+2,462
| +17% | +$24.3K |
|
2663
Mission Produce
AVO
$1.15B
| $166K | ﹤0.01% |
13,932
+1,870
| +16% | +$19.9K |
|
|
FSP
2664
Franklin Street Properties
FSP
$46.5M
| $166K | ﹤0.01% |
72,826
| – | – |
|
2665
Zymeworks
ZYME
$1.84B
| $165K | ﹤0.01% |
15,664
+2,351
| +18% | +$26.1K |
|
|
PTVE
2666
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $164K | ﹤0.01% |
+11,444
| New | +$162K |
|
2667
Rimini Street
RMNI
$467M
| $163K | ﹤0.01% |
49,697
| – | – |
|
2668
Westwood Holdings Group
WHG
$184M
| $163K | ﹤0.01% |
13,200
| – | – |
|
|
BIG
2669
DELISTED
Big Lots, Inc.
BIG
| $163K | ﹤0.01% |
37,421
+11,915
| +47% | +$63K |
|
2670
AST SpaceMobile
ASTS
$21.5B
| $161K | ﹤0.01% |
55,335
+22,987
| +71% | +$77.2K |
|
2671
Cadiz
CDZI
$295M
| $161K | ﹤0.01% |
55,305
-6,906
| -11% | -$19K |
|
|
MPX
2672
DELISTED
Marine Products Corp
MPX
| $161K | ﹤0.01% |
13,633
+143
| +1% | +$1.54K |
|
|
PVBC
2673
DELISTED
Provident Bancorp
PVBC
| $161K | ﹤0.01% |
17,600
| – | – |
|
2674
EVgo
EVGO
$519M
| $160K | ﹤0.01% |
63,392
+6,633
| +12% | +$17.2K |
|
|
CHMI
2675
Cherry Hill Mortgage Investment Corp
CHMI
$108M
| $159K | ﹤0.01% |
44,762
| – | – |
|
Similar funds
T. Rowe Price Associates's Q1 2024 Portfolio in Review
As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
- T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
- T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
- T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
- T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.
Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.